Portal:Blau/CoveredPathways
From WikiPathways
(Difference between revisions)
| Line 1: | Line 1: | ||
{| class="wikitable sortable" style="float:left; margin-left: 10px;" | {| class="wikitable sortable" style="float:left; margin-left: 10px;" | ||
| - | ! Chapter ed. 5 || Title || Links WP || Chapter ed. 4 | + | ! Chapter ed. 5 || Title || Links WP || Chapter ed. 4 || Status |
|- | |- | ||
| - | | 13 || Disorders of pyrimidine and purine metabolism | | + | | 13 || Disorders of pyrimidine and purine metabolism || [https://www.wikipathways.org/index.php/Pathway:WP4224 WP4224] and [https://www.wikipathways.org/index.php/Pathway:WP4225 WP4225] || 41 || style="font-style: italic; color: blue;" | Approved |
|- | |- | ||
| - | | 16 || Disorders of glutathione metabolism || style="font-style: italic; color: red;" | [https://www.wikipathways.org/index.php/Pathway:WP4518 WP4518] || 42 | + | | 16 || Disorders of glutathione metabolism || style="font-style: italic; color: red;" | [https://www.wikipathways.org/index.php/Pathway:WP4518 WP4518] || 42 || style="font-style: italic; color: blue;" | Approved |
|- | |- | ||
| - | | 20 || Disorders of phenylalanine and tetrahydrobiopterin metabolism || [https://www.wikipathways.org/index.php/Pathway:WP4156 WP4156] || 1 | + | | 20 || Disorders of phenylalanine and tetrahydrobiopterin metabolism || [https://www.wikipathways.org/index.php/Pathway:WP4156 WP4156] || 1|| style="font-style: italic; color: blue;" | Approved |
|- | |- | ||
| - | | 21 || Disorders of tyrosine metabolism || [https://www.wikipathways.org/index.php/Pathway:WP4506 WP4506] || 2 | + | | 21 || Disorders of tyrosine metabolism || [https://www.wikipathways.org/index.php/Pathway:WP4506 WP4506] || 2|| style="font-style: italic; color: blue;" | Approved |
|- | |- | ||
| - | | 22 || Disorders of sulfur amino acid and sulfide metabolism || [https://www.wikipathways.org/index.php/Pathway:WP4292 WP4292] || 3 | + | | 22 || Disorders of sulfur amino acid and sulfide metabolism || [https://www.wikipathways.org/index.php/Pathway:WP4292 WP4292] || 3|| style="font-style: italic; color: blue;" | Approved |
|- | |- | ||
| - | | 28 || Disorders of cobalamin metabolism || [https://www.wikipathways.org/index.php/Pathway:WP4271 WP4271] || 13 | + | | 28 || Disorders of cobalamin metabolism || [https://www.wikipathways.org/index.php/Pathway:WP4271 WP4271] || 13|| style="font-style: italic; color: blue;" | Approved |
|- | |- | ||
| - | | 29 || Disorders of folate metabolism|| [https://www.wikipathways.org/index.php/Pathway:WP4259 WP4259] and [https://www.wikipathways.org/index.php/Pathway:WP4288 WP4288] || 10 | + | | 29 || Disorders of folate metabolism|| [https://www.wikipathways.org/index.php/Pathway:WP4259 WP4259] and [https://www.wikipathways.org/index.php/Pathway:WP4288 WP4288] || 10|| style="font-style: italic; color: blue;" | Approved |
|- | |- | ||
| - | | 31 || Disorders of thiamine metabolism || [https://www.wikipathways.org/index.php/Pathway:WP4297 WP4297] || 15 | + | | 31 || Disorders of thiamine metabolism || [https://www.wikipathways.org/index.php/Pathway:WP4297 WP4297] || 15|| style="font-style: italic; color: blue;" | Approved |
|- | |- | ||
| - | | 34 || Vitamin B6 -Dependent and Responsive Disorders || [https://www.wikipathways.org/index.php/Pathway:WP4228 WP4228] || 11 | + | | 34 || Vitamin B6 -Dependent and Responsive Disorders || [https://www.wikipathways.org/index.php/Pathway:WP4228 WP4228] || 11|| style="font-style: italic; color: blue;" | Approved |
|- | |- | ||
| - | | 35 || Disorders of molybdenum metabolism || [https://www.wikipathways.org/index.php/Pathway:WP4507 WP4507] and [https://www.wikipathways.org/index.php/Pathway:WP4504 WP4504] || 12 | + | | 35 || Disorders of molybdenum metabolism || [https://www.wikipathways.org/index.php/Pathway:WP4507 WP4507] and [https://www.wikipathways.org/index.php/Pathway:WP4504 WP4504] || 12|| style="font-style: italic; color: blue;" | Approved |
|- | |- | ||
| - | | 42 || Disorders of pyruvate and Krebs cycle metabolism || [https://www.wikipathways.org/index.php/Pathway:WP4236 WP4236] || 20 | + | | 42 || Disorders of pyruvate and Krebs cycle metabolism || [https://www.wikipathways.org/index.php/Pathway:WP4236 WP4236] || 20|| style="font-style: italic; color: blue;" | Approved |
|- | |- | ||
| - | | 53 || Disorders of lipoprotein metabolism || [https://www.wikipathways.org/index.php/Pathway:WP4522 WP4522] || 43 | + | | 53 || Disorders of lipoprotein metabolism || [https://www.wikipathways.org/index.php/Pathway:WP4522 WP4522] || 43|| style="font-style: italic; color: blue;" | Approved |
|- | |- | ||
| - | | 55 || Disorders of steroid metabolism || [https://www.wikipathways.org/index.php/Pathway:WP4523 WP4523] and [https://www.wikipathways.org/index.php/Pathway:WP4524 WP4524] || 37 | + | | 55 || Disorders of steroid metabolism || [https://www.wikipathways.org/index.php/Pathway:WP4523 WP4523] and [https://www.wikipathways.org/index.php/Pathway:WP4524 WP4524] || 37|| style="font-style: italic; color: blue;" | Approved |
|- | |- | ||
| - | | 60 || Lysosomal storage disorders || [https://www.wikipathways.org/index.php/Pathway:WP4153 WP4153] || 25 | + | | 60 || Lysosomal storage disorders || [https://www.wikipathways.org/index.php/Pathway:WP4153 WP4153] || 25|| style="font-style: italic; color: blue;" | Approved |
|- | |- | ||
| - | | 66 || Congenital disorders of N-linked and O-linked glycosylation || [https://www.wikipathways.org/index.php/Pathway:WP4521 WP4521] || 30 | + | | 66 || Congenital disorders of N-linked and O-linked glycosylation || [https://www.wikipathways.org/index.php/Pathway:WP4521 WP4521] || 30|| style="font-style: italic; color: blue;" | Approved |
|- | |- | ||
| - | | 69 || Cerebral organic acidurias || [https://www.wikipathways.org/index.php/Pathway:WP4519 WP4519] || 8 | + | | 69 || Cerebral organic acidurias || [https://www.wikipathways.org/index.php/Pathway:WP4519 WP4519] || 8|| style="font-style: italic; color: blue;" | Approved |
|- | |- | ||
|} | |} | ||
Revision as of 13:17, 24 August 2020
| Chapter ed. 5 | Title | Links WP | Chapter ed. 4 | Status |
|---|---|---|---|---|
| 13 | Disorders of pyrimidine and purine metabolism | WP4224 and WP4225 | 41 | Approved |
| 16 | Disorders of glutathione metabolism | WP4518 | 42 | Approved |
| 20 | Disorders of phenylalanine and tetrahydrobiopterin metabolism | WP4156 | 1 | Approved |
| 21 | Disorders of tyrosine metabolism | WP4506 | 2 | Approved |
| 22 | Disorders of sulfur amino acid and sulfide metabolism | WP4292 | 3 | Approved |
| 28 | Disorders of cobalamin metabolism | WP4271 | 13 | Approved |
| 29 | Disorders of folate metabolism | WP4259 and WP4288 | 10 | Approved |
| 31 | Disorders of thiamine metabolism | WP4297 | 15 | Approved |
| 34 | Vitamin B6 -Dependent and Responsive Disorders | WP4228 | 11 | Approved |
| 35 | Disorders of molybdenum metabolism | WP4507 and WP4504 | 12 | Approved |
| 42 | Disorders of pyruvate and Krebs cycle metabolism | WP4236 | 20 | Approved |
| 53 | Disorders of lipoprotein metabolism | WP4522 | 43 | Approved |
| 55 | Disorders of steroid metabolism | WP4523 and WP4524 | 37 | Approved |
| 60 | Lysosomal storage disorders | WP4153 | 25 | Approved |
| 66 | Congenital disorders of N-linked and O-linked glycosylation | WP4521 | 30 | Approved |
| 69 | Cerebral organic acidurias | WP4519 | 8 | Approved |
Information on Pathway Curation:
This Table provides an overview of which chapters have been covered by WikiPathways. Approved pathways are coloured blue; pathways which still need work (however are a part of the database) are coloured orange.
Tip: Click on the arrows behind the Table headers to sort this table based on Chapter number (edition 4 and 5 available), title and WikiPathways reference.
Pathway Visualisations
View all digitized Pathways from the Physician's Guide to the Diagnosis, Treatment, and Follow-Up of Inherited Metabolic Diseases by Blau et al.
How to add a pathway to the portal
The list of Featured Pathways is not static and can be updated at any time. If you know of a pathway that should be added, please contact Denise Slenter.
